THRX

Theravance, Inc. News Headlines

$35.96
*  
0.25
  negative  
0.7%
Get THRX Alerts
*Delayed - data as of Jun. 19, 2013 9:35 ET 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    THRX Real Time
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Elan Explores Sale Options - Analyst Blog
6/17/2013 4:30:29 PM - Zacks.com

Elan Shareholders Bring Management To Heel
6/17/2013 1:40:00 PM - Investopedia

Royalty Pharma's Offer for Elan Lapses
6/17/2013 9:05:00 AM - Dow Jones Business News

Theravance Says Disappointed Over Elan Shareholders Rejecting Transaction
6/17/2013 8:39:00 AM - RTT News

Elan Shareholder Vote Nixes Royalty Pharma Takeover -- For Now
6/17/2013 7:44:00 AM - TheStreet

Wall Street On Recovery Path
6/17/2013 6:31:00 AM - RTT News

Elan Shares Climb 8% On Announcement Of Formal Sale Process
6/14/2013 11:10:00 AM - RTT News

Royalty Pharma Says Elan ADS Holders Vote Against Theravance, AOP Transactions
6/14/2013 2:02:00 AM - RTT News

Theravance To Present At Goldman Sachs Healthcare Conference;webcast At 11:40 AM
6/13/2013 10:40:00 AM - RTT News

Elan Corp Urges Shareholders To Reject Royalty Pharma's Acquisition Offer
6/11/2013 9:09:00 AM - RTT News

AstraZeneca Pays Up To Patch Up Another Key Area
6/10/2013 12:55:00 PM - Investopedia

AstraZeneca Buys Pearl for $1.15 Billion
6/10/2013 5:05:00 AM - Dow Jones Business News

Elan Board Rejects Royalty Pharma Offer Yet Again
6/10/2013 3:30:00 AM - RTT News

Royalty Pharma Raises Elan Offer to $8 Billion
6/7/2013 10:55:00 AM - Dow Jones Business News

Theravance To Present At Jefferies Healthcare Conference; Webcast At 10:30 AM ET
6/5/2013 9:30:00 AM - RTT News

Elan Rejects Royalty Offer Again - Analyst Blog
5/24/2013 4:28:15 PM - Zacks.com

Elan Rejects Latest Royalty Pharma Approach
5/23/2013 2:55:00 PM - Dow Jones Business News

Royalty Pharma Lowers Acceptance Threshold For Elan Offer
5/23/2013 8:17:00 AM - Dow Jones Business News

Elan Provides Strategic Update - Analyst Blog
5/21/2013 4:27:15 PM - Zacks.com

Royalty Pharma Lifts Elan Bid To $12.50 Per Share - Update
5/20/2013 2:09:00 PM - RTT News

Royalty Pharma Confirms Increased $12.50/Share Cash Offer For Elan Corp.
5/20/2013 12:19:00 PM - RTT News

Elan Sets Out Deal Plans
5/20/2013 6:15:00 AM - Dow Jones Business News

Elan To Offer $800 Mln Of Senior Notes Due 2021; Announces Several Transactions
5/20/2013 2:28:00 AM - RTT News

The Billion Dollar COPD Deal: Who Gains The Most?
5/17/2013 11:27:00 AM - Seeking Alpha

Playing Momentum With Insiders
5/16/2013 12:19:00 PM - Seeking Alpha